Occudo Quantitative Strategies’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
Occudo Quantitative Strategies's IRMD Position: Q3 2026 in Review
Occudo Quantitative Strategies sold out of iRadimed (IRMD) in Q3 2026, closing a stake of 5,154 shares — an estimated $493K sold.
Occudo Quantitative Strategies first reported a position in IRMD in Q2 2023 and held it in 5 quarters. The position peaked at $493K in Q2 2026. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- Occudo Quantitative Strategies reported no remaining iRadimed position as of Q3 2026 after selling out during the quarter.
- Occudo Quantitative Strategies sold 5,154 iRadimed shares in Q3 2026, an estimated $493K.
- Occudo Quantitative Strategies first reported a position in iRadimed in Q2 2023 and held it in 5 quarters.
- Occudo Quantitative Strategies's iRadimed position peaked at $493K in Q2 2026.
- 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on Occudo Quantitative Strategies's 13F filing for Q3 2026, filed 16 Nov 2026.